Metso lowers its EBITA guidance for the Pulp, Paper and

New Post Public Reply Private Reply Replies (0) Message Board

News Desk 2018

Dec 19, 2013 at 9:00 AM

Metso lowers its EBITA guidance for the Pulp, Paper and Power segment (to be transferred to Valmet) for 2013

Metso Corporation's stock exchange release on December 19, 2013 at 3:45 p.m. local time Metso has decided to lower its EBITA guidance for the Pulp, Paper and Power segment for 2013. Pulp, Paper and Power segment's net sales and EBITA before non-recurring items were previously expected to be significantly lower compared to 2012. Its net sales and EBITA before non-recurring items during the second half were expected to be at about the first half's level. The updated guidance now indicates that EBITA before non-recurring items of the Pulp, Paper and Power segment is expected to be significantly lower than the level booked during the first half, mainly because of a delay linked to a major pulp project delivery and the higher-than-expected costs incurred as a result. The project in question is an individual case and is not expected to have a wider impact on the Pulp, Paper and Power segment. Capacity utilization in the company's paper and power businesses has also been lower than expected. Metso's overall guidance for the Group remains unchanged: it is estimated that net sales and EBITA before non-recurring items in 2013 will be significantly lower than those in 2012. Previous guidance for the Pulp, Paper and Power segment: Both net sales and EBITA before non-recurring items are expected to be significantly lower compared to 2012. Net sales and EBITA during the second half are expected to be at about the first half's level. Updated guidance for the Pulp, Paper and Power segment: Both net sales and EBITA before non-recurring items are expected to be significantly lower compared to 2012. Net sales during the second half are expected to be at the level booked during the first half of 2012 (EUR 1,345 million), but EBITA before non-recurring items is expected to be significantly lower than during the first half of 2013 (EUR 55.5 million). Metso's Extraordinary General Meeting decided on October 1, 2013 that Metso will demerge through a partial demerger and that all the assets, debts, and liabilities relating to Metso's Pulp, Paper and Power businesses will transfer, without liquidation, from Metso to Valmet Corporation. The future Valmet Corporation is a leading global developer and supplier of services and technologies for the pulp, paper, and energy industries. Our 11,000 professionals around the world work close to our customers and are committed to moving our customers' performance forward - every day. Valmet's services cover everything from maintenance outsourcing to mill and plant improvements and spare parts. Our strong technology offering includes entire pulp mills, tissue, board and paper production lines, as well as power plants for bio-energy production. The company has over 200 years of industrial history and will be reborn through the demerger of the pulp, paper and power businesses from Metso Group on December 31, 2013. Valmet's net sales in 2012 were approximately EUR 3 billion. Valmet's objective is to become the global champion in serving its customers. www.valmet.com www.twitter.com/valmetglobal Metso is a global supplier of technology and services to customers in the process industries, including mining, construction, pulp and paper, power, and oil and gas. Our 30,000 professionals based in over 50 countries contribute to sustainability and deliver profitability to customers worldwide. Metso's shares are listed on the NASDAQ OMX Helsinki Ltd. www.metso.com, www.twitter.com/metsogroup Further information, please contact: Markku Honkasalo, CFO, future Valmet Corporation, tel. +358 10 672 0008 Hanna-Maria Heikkinen, Vice President, Investor Relations, future Valmet Corporation tel. +358 10 672 0007 Metso Corporation Harri Nikunen CFO Juha Rouhiainen VP, Investor Relations Distribution: NASDAQ OMX Helsinki Ltd Media www.metso.com [HUG#1751236]

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Roofr Unveils AI Tools: Shaping Roofing's Future

Making Waves in Roofing: Roofr's Big Moves Listen up, folks. When a company like Roofr announces new tech, contractors better pay attention. The roofing industry—often overlooked by the flashy tech scene—just got hit with some slick new tools. Today, Roofr held its semi-annual virtual event, Roofr Builds, unraveling a slew of updates that might just streamline the way...

QUA's EnviQ RF 30: A Game-Changer in Water Reuse

Revolutionizing Water Treatment with Compact Solutions When you walk into a wastewater treatment facility, the last thing you expect is elegance. But elegance in efficiency is exactly what QUA is bringing to the table with their new EnviQ RF 30 compact membrane unit. This isn't your average pipe dream—it's a full-blown reality shaping the future of water reuse. A...

Amynta's Southern States Deal: A Strategic Move?

Digging Into Amynta's Latest Acquisition Alright, pull up a stool because Amynta Group just wrapped up a deal that could stir up the insurance pot a little. They snagged Southern States Underwriters, a specialty managing general underwriter focusing on commercial property and casualty insurance for the agribusiness sector. With this acquisition, Amynta doesn't just...

Ford Foundation's New Strategy Tackles Global Democracy

New Directions in a Changing World Standing at a crossroads of geopolitical upheaval and global uncertainty, the Ford Foundation is shaking things up with a fresh playbook aimed squarely at bolstering democracy across the globe. On October 22, 2026, they rolled out a game plan that's all about reinforcing the backbone of democratic values, essential freedoms, and...

Scage Future's ADS Ratio Change: What's Next?

A New Era for Scage Future's ADS Holders You don't wake up every day to catch a one-for-fifteen reverse ADS split staring you right in the face, but for Scage Future's shareholders, that's exactly what's happening. The company, a pretty big deal in the zero-emission heavy-duty vehicle scene, made waves by announcing they're tinkering with their ADS ratio. You see, the...

MISO Unveils Major Energy Grid Project in Iowa

Ameren's Game Plan in Iowa There's always something cooking in the energy grids, and this time, MISO's picking up the phone to call a heavy-hitting consortium. Ameren Corp, which flies under the NYSE as AEE, teams up with GridLiance and Dairyland Power Cooperative to kickstart an ambitious grid venture in Iowa. Now, if you're a betting trader, you'd want to size up how...

Prepare Denver Sprinkler Systems Before Winter Strikes

Colorado's Unpredictable Weather: Don't Get Caught Cold The leaves turning color might be the signal of fall, but in Colorado, the weather seems to have a mind of its own—sunny one moment, bone-chilling the next. Denver homeowners, it's time to take a hard look at your outdoor sprinkler systems. Why? Because those freezing nights can sneak up faster than you'd think and...

Iowa Voters Strongly Favor Funding Water Quality Trust

A Growing Concerns in Iowa From the heart of Iowa comes a noise that state leaders better not ignore. Water quality—something folks maybe dismissed as a bureaucratic afterthought in the past—is now screaming from every corner of Iowa's farmland and urban landscapes. You'd barely bat an eye in Iowa now without hearing someone fretting over murky streams or unsafe...

Dott's Q3 2026: Micromobility Growth Soars High

Riding the Wave of Profit in Micromobility Sometimes all you need is a quick jolt of genius to turn the wheels of fortune. Dott seems to have hit that sweet spot in Q3 of 2026. Deploying 45,000 new vehicles wasn’t just a logistical feat; it was a calculated bet that paid off handsomely, bolstering their business to soaring heights. Performance that Packs a Punch The Q3...

Harbour BioMed's Batoclimab Injected Into Myasthenia Market

China's Green Light for Batoclimab When a new drug approval hits, particularly in a crucial market like China, it's a big deal. Harbour BioMed's recent go-ahead from the National Medical Products Administration (NMPA) for their Batoclimab injection is no exception. This marks the first full clinical cycle completion of an anti-FcRn treatment for generalized myasthenia...